Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
There is evidence that thyroid hormone T3 increases serotonergic neurotransmission. Therefore, T3 addition to antidepressants may improve treatment response in major depression. In nonrefractory depression, T3 addition to tricyclic antidepressants indeed accelerates treatment response. Current therapeutic practice favors selective serotonin reuptake inhibitors. This is the first study to investigate the efficacy of T3 addition to paroxetine in major depression. One hundred thirteen patients with major depressive disorder were randomly assigned to 8 wk of double-blind outpatient treatment with low-dose T3 (25 microg), high-dose T3 (25 microg twice daily), or placebo in addition to paroxetine 30 mg daily. A total of 106 patients started treatment and were included in the outcome analysis. Response rate after 8 wk (reduction of Hamilton Rating Scale for Depression score > or = 50%) was 46% in all three treatment arms (P = 0.99). T3 addition did not accelerate clinical response to paroxetine, nor was an effect of T3 found when only women were analyzed. Patients on T3 addition reported more adverse events than patients on placebo comedication. In conclusion, these results do not support a role for T3 addition to selective serotonin reuptake inhibitors in the treatment of nonrefractory major depressive disorder. On the contrary, more adverse reactions occurred in T3-treated patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain
Bauer, M., Heinz, A., & Whybrow, P. C. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000963 · Cited by 370
Altshuler, L. L., Bauer, M., Frye, M. A., Gitlin, M. J., Mintz, J., Szuba, M. P., Leight, K. L., & Whybrow, P. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1617 · Cited by 250
Cited by
Nierenberg, A. A., Fava, M., Trivedi, M. H., Wisniewski, S. R., Thase, M. E., McGrath, P. J., Alpert, J. E., Warden, D., Luther, J. F., Niederehe, G., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1519 · Cited by 559
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The Thyroid‐Brain Interaction in Thyroid Disorders and Mood Disorders
Bauer, M., Goetz, T., Glenn, T., & Whybrow, P. C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01774.x · Cited by 438
The burden of severe depression: A review of diagnostic challenges and treatment alternatives
Nemeroff, C. B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.008 · Cited by 295
Sex differences and the neurobiology of affective disorders
Rubinow, D. R., & Schmidt, P. J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0148-z · Cited by 280
Metadata
- Authors
- Appelhof, B. C., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Huyser, J., Schene, A. H., Tijssen, J. G. P., & Wiersinga, W. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-12
- Volume
- 89
- Issue
- 12
- Pages
- 6271-6276
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1998960607
- Cited by
- 63
- References
- 2
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder. https://app.cochat.ai/papers/10.1210/jc.2004-1147
- The paper
- Appelhof, B. C., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Huyser, J., Schene, A. H., Tijssen, J. G. P., & Wiersinga, W. M. (2004). Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2004-1147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.